Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Curr Opin Biotechnol. 2010 Oct 16;21(6):808–818. doi: 10.1016/j.copbio.2010.09.015

Figure 1.

Figure 1

Examples of current therapeutics against important parasitic diseases with trade names, target disease (entries 1–6, Table 1), and year of discovery. *Natural product or based on a natural product scaffold. aAdministered as a mixture of stereoisomers. bHAT(I): First stage of Human African trypanosomiasis; cHAT(II): Second stage of Human African trypanosomiasis.